Investigating how chemical modifications in RNA affect blood vessel health and disease.
Mechanosensitive M7G epitranscriptome in endothelial health and disease
This study is looking at how certain chemical changes in RNA might affect the health of blood vessels, which could help us understand and improve treatments for conditions like atherosclerosis.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10992139 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of RNA chemical modifications, specifically N7-methylguanosine (m7G), in the health and disease of blood vessels. By examining how these modifications influence endothelial cell functions, the study aims to uncover new insights into vascular diseases such as atherosclerosis. The approach involves mapping these modifications in endothelial mRNA and exploring their relationship with blood flow and vascular pathophysiology. Patients may benefit from advancements in treatment strategies targeting these molecular mechanisms.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for or diagnosed with atherosclerotic cardiovascular disease.
Not a fit: Patients with non-vascular related conditions or those not affected by atherosclerosis may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for preventing or treating atherosclerotic cardiovascular disease.
How similar studies have performed: While the exploration of m7G in endothelial health is relatively novel, previous studies on m6A modifications have shown promising results in understanding cancer biology.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: He, Chuan — University of Chicago
- Study coordinator: He, Chuan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.